Kee BL - Search Results

1

Dual Targeting of Apoptotic and Signaling Pathways in T-Lineage Acute Lymphoblastic Leukemia.

Saygin C, Giordano G, Shimamoto K, Eisfelder B, Thomas-Toth A, Venkataraman G, Ananthanarayanan V, Vincent TL, DuVall A, Patel AA, Chen Y, Tan F, Anthony SP, Chen Y, Shen Y, Odenike O, Teachey DT, Kee BL, LaBelle J, Stock W. Saygin C, et al. Among authors: kee bl. Clin Cancer Res. 2023 Aug 15;29(16):3151-3161. doi: 10.1158/1078-0432.CCR-23-0415. Clin Cancer Res. 2023. PMID: 37363966 Free PMC article.

2

Loss of thymocyte competition underlies the tumor suppressive functions of the E2a transcription factor in T lymphocyte acute lymphoblastic leukemia.

Parriott G, Hegermiller E, Morman RE, Frank C, Saygin C, Stock W, Bartom ET, Kee BL. Parriott G, et al. Among authors: kee bl. bioRxiv [Preprint]. 2023 Apr 25:2023.04.23.537993. doi: 10.1101/2023.04.23.537993. bioRxiv. 2023. PMID: 37163059 Free PMC article. Updated. Preprint.

3

Loss of thymocyte competition underlies the tumor suppressive functions of the E2a transcription factor in T-ALL.

Parriott G, Hegermiller E, Morman RE, Frank C, Saygin C, Stock W, Bartom ET, Kee BL. Parriott G, et al. Among authors: kee bl. Leukemia. 2024 Mar;38(3):491-501. doi: 10.1038/s41375-023-02123-4. Epub 2023 Dec 28. Leukemia. 2024. PMID: 38155245

4

E Protein Transcription Factors as Suppressors of T Lymphocyte Acute Lymphoblastic Leukemia.

Parriott G, Kee BL. Parriott G, et al. Among authors: kee bl. Front Immunol. 2022 Apr 20;13:885144. doi: 10.3389/fimmu.2022.885144. eCollection 2022. Front Immunol. 2022. PMID: 35514954 Free PMC article. Review.

5

Targeting the NF-kappaB signaling pathway in Notch1-induced T-cell leukemia.

Vilimas T, Mascarenhas J, Palomero T, Mandal M, Buonamici S, Meng F, Thompson B, Spaulding C, Macaroun S, Alegre ML, Kee BL, Ferrando A, Miele L, Aifantis I. Vilimas T, et al. Among authors: kee bl. Nat Med. 2007 Jan;13(1):70-7. doi: 10.1038/nm1524. Epub 2006 Dec 17. Nat Med. 2007. PMID: 17173050

6

Oncogenic and Tumor Suppressor Functions for Lymphoid Enhancer Factor 1 in E2a^-/- T Acute Lymphoblastic Leukemia.

Carr T, McGregor S, Dias S, Verykokakis M, Le Beau MM, Xue HH, Sigvardsson M, Bartom ET, Kee BL. Carr T, et al. Among authors: kee bl. Front Immunol. 2022 Mar 18;13:845488. doi: 10.3389/fimmu.2022.845488. eCollection 2022. Front Immunol. 2022. PMID: 35371057 Free PMC article.

7

Notch1 co-opts lymphoid enhancer factor 1 for survival of murine T-cell lymphomas.

Spaulding C, Reschly EJ, Zagort DE, Yashiro-Ohtani Y, Beverly LJ, Capobianco A, Pear WS, Kee BL. Spaulding C, et al. Among authors: kee bl. Blood. 2007 Oct 1;110(7):2650-8. doi: 10.1182/blood-2007-04-084202. Epub 2007 Jun 21. Blood. 2007. PMID: 17585052 Free article.

8

Sox4 B-lymphocyte progenitors.

Kee BL. Kee BL. Blood. 2014 Jun 26;123(26):4009-10. doi: 10.1182/blood-2014-05-574178. Blood. 2014. PMID: 24970928 Free article.

9

Transcriptional regulation of lymphocyte development.

Dias S, Xu W, McGregor S, Kee B. Dias S, et al. Curr Opin Genet Dev. 2008 Oct;18(5):441-8. doi: 10.1016/j.gde.2008.07.015. Epub 2008 Sep 5. Curr Opin Genet Dev. 2008. PMID: 18775782 Free PMC article. Review.

10

Inhibitor of DNA binding 3 limits development of murine slam-associated adaptor protein-dependent "innate" gammadelta T cells.

Verykokakis M, Boos MD, Bendelac A, Adams EJ, Pereira P, Kee BL. Verykokakis M, et al. Among authors: kee bl. PLoS One. 2010 Feb 19;5(2):e9303. doi: 10.1371/journal.pone.0009303. PLoS One. 2010. PMID: 20174563 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

88 results

Search Page